Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Bullboard Posts
Comment by longterm56on Feb 02, 2019 12:02pm
92 Views
Post# 29310000

RE:RE:RE:RE:SeekingAlpha.com report now available to all

RE:RE:RE:RE:SeekingAlpha.com report now available to allThis one works, thanks -


SPCEO1 wrote: Try this link:https://seekingalpha.com/instablog/24010943-first-genesis-consulting/5266481-theratechnologies-egrifta-intriguing-nash-play-likely-never-heard-imminent-catalyst


SPCEO1 wrote: It worked earlier, but something must have gone amiss. Check it again later and maybe it will be fixed.

longterm56 wrote:
SPCEO1 wrote: The author of this report has posted it on a blog that you can access here:

https://seekingalpha.com/instablog/24010943-first-genesis-consulting/5266321-theratechnologies-egrifta-intriguing-nash-play-likely-never-heard-imminent-catalyst
 


This link doesn't work for me, does it for others?

  -LT

 




Bullboard Posts